TNF-α is considered the key molecule, shown by the fact that when mice with TNBS-induced colitis were treated by intraperitoneal injection of antibodies to TNF-α, improvements of both the clinical and histopathological signs of disease were found [81]. The gene discussed is TNF; the disease is colitis.